PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Sarcoidosis D012507 13 associated lipids
Pleurisy D010998 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cataract D002386 34 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Sarcoma 180 D012510 21 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Hyperemia D006940 25 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Peritonitis D010538 38 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Ascariasis D001196 3 associated lipids
Thyroid Diseases D013959 8 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Astrocytoma D001254 15 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Erythema D004890 22 associated lipids
Hyperalgesia D006930 42 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Hyperlipidemias D006949 73 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Kanai K et al. Effect of prostaglandin D2 on VEGF release by nasal polyp fibroblasts. 2016 Allergol Int pmid:27091669
Akabane H et al. Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells. 2006 Allergol Int pmid:17130681
Ishimura M et al. Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea. 2006 Allergol Int pmid:17130683
Yoshimura T et al. Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma. 2008 Allergol Int pmid:18797183
Horak F et al. Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients. 1998 Allergy pmid:9491231
Howarth PH Mediators of nasal blockage in allergic rhinitis. 1997 Allergy pmid:9353555
Abdelaziz MM et al. The potential of active metabolites of antihistamines in the management of allergic disease. 2000 Allergy pmid:10843422
Ito W et al. Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils. 2007 Allergy pmid:17362253
Holgate ST et al. The contribution of mast cell mediators to acute allergic reactions in human skin and airways. 1988 Allergy pmid:2451448
Wang XS et al. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease. 2007 Allergy pmid:17508965
Church MM et al. The mediator and cellular basis of the allergic response. 1988 Allergy pmid:2462372
Okayama Y et al. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin. 1994 Allergy pmid:7518654
Gulliksson M et al. Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells. 2006 Allergy pmid:17073880
Takafuji S et al. Release of granule proteins from human eosinophils stimulated with mast-cell mediators. 1998 Allergy pmid:9821474
Pérez-Novo CA et al. CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue. 2010 Allergy pmid:19839971
Ono E et al. Salicylamide-induced anaphylaxis: increased urinary leukotriene E4 and prostaglandin D2 metabolite. 2008 Allergy pmid:18315738
Campbell AM et al. Modulation of eicosanoid and histamine release from human dispersed lung cells by terfenadine. 1993 Allergy pmid:7681268
Guyer BJ et al. Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis. 2006 May-Jun Allergy Asthma Proc pmid:16913263
Naclerio RM Additional properties of cetirizine, a new H1 antagonist. 1991 May-Jun Allergy Proc pmid:1680095
Nishino S et al. Salivary prostaglandin concentrations: possible state indicators for major depression. 1989 Am J Psychiatry pmid:2627202
Okano M et al. Presence and characterization of prostaglandin D2-related molecules in nasal mucosa of patients with allergic rhinitis. 2006 May-Jun Am J Rhinol pmid:16871941
Paolini JF et al. Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia. 2008 Am. J. Cardiol. pmid:18308010
Song HH et al. Anti-inflammatory and anti-allergic effect of Agaricus blazei extract in bone marrow-derived mast cells. 2012 Am. J. Chin. Med. pmid:22928836
Kawabe Y et al. Genesis and recovery of ethanol-induced gastric lesions in rats: possible involvement of prostaglandin D2. 1989 Am. J. Gastroenterol. pmid:2916522
Fitscha P et al. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. 1985 Am. J. Hematol. pmid:3885723
Sinzinger H et al. Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction. 1991 Am. J. Hematol. pmid:1899965
Wasserman SI The mast cell and theophylline in asthma. 1985 Am. J. Med. pmid:3002176
Ruano D et al. Family-based and case-control studies reveal no association of lipocalin-type prostaglandin D2 synthase with schizophrenia. 2007 Am. J. Med. Genet. B Neuropsychiatr. Genet. pmid:17230501
Afrin LB Polycythemia from mast cell activation syndrome: lessons learned. 2011 Am. J. Med. Sci. pmid:21642812
Afrin LB Mast cell activation syndrome as a significant comorbidity in sickle cell disease. 2014 Am. J. Med. Sci. pmid:25171546
Newman JH and Sheller JR Arachidonic acid metabolites in the healthy and diseased lung. 1984 Am. J. Med. Sci. pmid:6091454
White RP et al. Eicosanoid levels in CSF of premature infants with posthemorrhagic hydrocephalus. 1990 Am. J. Med. Sci. pmid:2321665
Zhang YF et al. Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense. 2006 Am. J. Nephrol. pmid:17183189
Chana RS et al. Statins but not thiazolidinediones attenuate albumin-mediated chemokine production by proximal tubular cells independently of endocytosis. 2008 Am. J. Nephrol. pmid:18535368
Zhang YJ et al. Effect of 15d-PGJ2 on the expression of CD40 and RANTES induced by IFN-gamma and TNF-alpha on renal tubular epithelial cells (HK-2). 2006 Am. J. Nephrol. pmid:16864989
Norwitz ER and Wilson T Secretory component: a potential regulator of endometrial-decidual prostaglandin production in early human pregnancy. 2000 Am. J. Obstet. Gynecol. pmid:10920317
Rao PS et al. Prostaglandin D2 in canine endotoxic shock. Hemodynamic, hematologic, biochemical, and blood gas analyses. 1984 Am. J. Obstet. Gynecol. pmid:6424477
Rao PS et al. Dose-dependent effects of prostaglandin D2 on hemodynamics, renal function, and blood gas analyses. 1987 Am. J. Obstet. Gynecol. pmid:3555078
Abelson MB et al. Aspirin therapy in vernal conjunctivitis. 1983 Am. J. Ophthalmol. pmid:6573138
Poncin S et al. Oxidative stress: a required condition for thyroid cell proliferation. 2010 Am. J. Pathol. pmid:20093493
Ugajin T et al. FcεRI, but not FcγR, signals induce prostaglandin D2 and E2 production from basophils. 2011 Am. J. Pathol. pmid:21712025
Yamamoto Y et al. Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2. 2011 Am. J. Pathol. pmid:21703412
Zamuner SR et al. Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2-derived prostaglandin d2. 2005 Am. J. Pathol. pmid:16251413
Jeon KI et al. Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation. 2014 Am. J. Pathol. pmid:24650561
Yang C et al. Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism. 2007 Am. J. Pathol. pmid:17255338
Mohri I et al. Inhibition of prostaglandin D synthase suppresses muscular necrosis. 2009 Am. J. Pathol. pmid:19359520
Marx N et al. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. 1998 Am. J. Pathol. pmid:9665460
Feldon SE et al. Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. 2006 Am. J. Pathol. pmid:17003477
Shimura C et al. Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin. 2010 Am. J. Pathol. pmid:20008150
Nakashiro KI et al. Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells. 2001 Am. J. Pathol. pmid:11485917
Poncin S et al. N-acetylcysteine and 15 deoxy-{delta}12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1{alpha}/interferon {gamma}-induced inhibitory effects in thyrocytes in vitro. 2010 Am. J. Pathol. pmid:20489149
Thomas PS et al. Tobacco smoke releases performed mediators from canine mast cells and modulates prostaglandin production. 1992 Am. J. Physiol. pmid:1636731
Goerg KJ et al. Antisecretory effect of prostaglandin D2 in rat colon in vitro: action sites. 1991 Am. J. Physiol. pmid:1676243
Keenan CM and Rangachari PK Contrasting effects of PGE2 and PGD2: ion transport in the canine proximal colon. 1991 Am. J. Physiol. pmid:2003610
Perreault T et al. Pulmonary vascular effects of prostaglandin D2 in newborn pig. 1990 Am. J. Physiol. pmid:2337164
Warren JB et al. PGD2 is an intermediate in agonist-stimulated nitric oxide release in rabbit skin microcirculation. 1994 Am. J. Physiol. pmid:7515584
Abran D et al. Regulation of prostanoid vasomotor effects and receptors in choroidal vessels of newborn pigs. 1997 Am. J. Physiol. pmid:9087666
Lippton HL et al. Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed. 1992 Am. J. Physiol. pmid:1348400
Rangachari PK and Betti PA Biological activity of metabolites of PGD2 on canine proximal colon. 1993 Am. J. Physiol. pmid:8498516
Peden DB et al. Hydrogen peroxide effects on rat mast cell function. 1994 Am. J. Physiol. pmid:8048546
Deffebach ME et al. Prostaglandins alter methacholine-induced secretion in ferret in vitro trachea. 1990 Am. J. Physiol. pmid:2407140
Chakraborti S et al. Oxidant-mediated activation of phospholipase A2 in pulmonary endothelium. 1989 Am. J. Physiol. pmid:2514605
Liakos P et al. ANG II AT1 and AT2 receptors both inhibit bFGF-induced proliferation of bovine adrenocortical cells. 1997 Am. J. Physiol. pmid:9357777
McGowan SE et al. Peroxisome proliferators alter lipid acquisition and elastin gene expression in neonatal rat lung fibroblasts. 1997 Am. J. Physiol. pmid:9435581
Thomas PS et al. Prostaglandin D2 production and identification of prostaglandin H synthase within canine mast cell granule. 1992 Am. J. Physiol. pmid:1514641
Ahlquist DA et al. Factors influencing metabolism of arachidonic acid in guinea pig gastric mucosa. 1983 Am. J. Physiol. pmid:6401937
Homma T and Malik KU Effect of secretin and caerulein in canine pancreas: relation to prostaglandins. 1983 Am. J. Physiol. pmid:6344655
Frieling T et al. Effects of the inflammatory mediator prostaglandin D2 on submucosal neurons and secretion in guinea pig colon. 1994 Am. J. Physiol. pmid:8304452
Nukina S et al. Glycogenolytic effect of adenosine involves ATP from hepatocytes and eicosanoids from Kupffer cells. 1994 Am. J. Physiol. pmid:8304463
Chapnick BM Divergent influences of leukotrienes C4, D4, and E4 on mesenteric and renal blood flow. 1984 Am. J. Physiol. pmid:6326595
Reiss TF et al. Local mediator release after antigen challenge of a bronchial segment in allergic dogs. 1989 Am. J. Physiol. pmid:2481982
Banks RO and Jacobson ED Renal vasodilation with ureteral occlusion and prostaglandins: attenuation by histamine H1 antagonists. 1985 Am. J. Physiol. pmid:2866716
Peden DB and Dailey L Modulation of mast cell functions by in vitro ozone exposure. 1995 Am. J. Physiol. pmid:7611432
Rabe KF et al. Hydrogen peroxide contracts human airways in vitro: role of epithelium. 1995 Am. J. Physiol. pmid:7573466
Gyenes M and De Groot H Prostanoid release by Kupffer cells upon hypoxia-reoxygenation: role of pHi and Cai2+. 1993 Am. J. Physiol. pmid:8384798
Katsuura G et al. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. 1990 Am. J. Physiol. pmid:1967907
Pucci ML et al. Cloning of mouse prostaglandin transporter PGT cDNA: species-specific substrate affinities. 1999 Am. J. Physiol. pmid:10484490
Keenan CM and Rangachari PK Eicosanoid interactions in the canine proximal colon. 1989 Am. J. Physiol. pmid:2539737
Drummond WH and Carter RL Cardiac depressant and circulatory effects of prostaglandin D2 in developing lambs. 1987 Am. J. Physiol. pmid:3468806
Inoue M et al. Interactions between brain acetylcholine and prostaglandins in control of vasopressin release. 1991 Am. J. Physiol. pmid:1877699
Abman SH and Accurso FJ Sustained fetal pulmonary vasodilation with prolonged atrial natriuretic factor and GMP infusions. 1991 Am. J. Physiol. pmid:1847014
Belegu M et al. beta-Adrenergic blockade of prostaglandin E2- and D2-induced erythroid colony formation. 1983 Am. J. Physiol. pmid:6579847
Chambers KT et al. PGJ2-stimulated beta-cell apoptosis is associated with prolonged UPR activation. 2007 Am. J. Physiol. Endocrinol. Metab. pmid:17148750
Cantley JL et al. Targeting steroid receptor coactivator 1 with antisense oligonucleotides increases insulin-stimulated skeletal muscle glucose uptake in chow-fed and high-fat-fed male rats. 2014 Am. J. Physiol. Endocrinol. Metab. pmid:25159329
Lupi R et al. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:14625208
Bulló M et al. Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2, and Delta12-PGJ2. 2005 Am. J. Physiol. Endocrinol. Metab. pmid:15713689
Weber SM et al. PPARgamma is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic beta-cells. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:14600076
Weber SM et al. PPARgamma ligands induce ER stress in pancreatic beta-cells: ER stress activation results in attenuation of cytokine signaling. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:15315910
Kershaw EE et al. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. 2007 Am. J. Physiol. Endocrinol. Metab. pmid:17848638
Weber SM et al. Inhibition of IFN-gamma -induced STAT1 activation by 15- deoxy-Delta 12,14-prostaglandin J2. 2003 Am. J. Physiol. Endocrinol. Metab. pmid:12517740
Zhang S et al. Role of prostaglandin D2 in mast cell activation-induced sensitization of esophageal vagal afferents. 2013 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:23471341
Orlichenko LS et al. Transcriptional regulation of CXC-ELR chemokines KC and MIP-2 in mouse pancreatic acini. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:20671197
Watanabe K et al. 15-deoxy-delta 12,14-prostaglandin J2 prevents inflammatory response and endothelial cell damage in rats with acute obstructive cholangitis. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:20056897
Ajuebor MN et al. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10898767
Ji Y et al. Activation of rat intestinal mucosal mast cells by fat absorption. 2012 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:22461027
Ceaser EK et al. Oxidized low-density lipoprotein and 15-deoxy-delta 12,14-PGJ2 increase mitochondrial complex I activity in endothelial cells. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12881207
Dumont I et al. Regulation of endothelial nitric oxide synthase by PGD(2) in the developing choroid. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10644584
Benkirane K et al. PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16155101
Taba Y et al. 15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12623786
Atkins KB et al. Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15345487